The conditional approval is supported by positive efficacy and safety data from RemeGen's comple

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Vor Biopharma (NASDAQ:VOR) with

Wedbush analyst Martin Fan maintains Vor Biopharma (NASDAQ:VOR) with a Neutral and raises the pr

Vor Biopharma (NASDAQ:VOR) reported quarterly losses of $(0.73) per share which beat the analyst con

Top Wall Street analysts changed their outlook on these top names. See analyst rating changes and up

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Vor Biopharma (NASDAQ:VOR) with

Wedbush analyst Martin Fan maintains Vor Biopharma (NASDAQ:VOR) with a Neutral and raises the pr

Vor Biopharma (NASDAQ:VOR) reported quarterly losses of $(1.63) per share which beat the analyst con

Jefferies analyst Farzin Haque initiates coverage on Vor Biopharma (NASDAQ:VOR) with a Buy rating

Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmu

Shares of Vor Biopharma Inc. (NASDAQ: VOR) are trading higher Friday after pricing a $14.05 private

U.S. stocks lower, Nasdaq falls 1%. Oxford Industries up 11.2% on strong earnings, raised dividend.

Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmu

The options will vest over a four-year period, with 25% of the shares vesting after 12 months and th

Wells Fargo analyst Sadia Rahman initiates coverage on Vor Biopharma (NASDAQ:VOR) with a Overweig

XCUR: 176% | Exicure shares are trading higher after the company announced results from its complete

  On Tuesday, 647 companies set new 52-week lows.

  During the session on Thursday, 461 stocks hit new 52-week lows.

  During Tuesday's session, 275 companies made new 52-week lows.

  During the Friday's sesion, 157 stocks hit new 52-week lows.

  On Thursday, 128 companies set new 52-week lows.